To further substantiate the results and better understand the role of ApoA1 in treating ALS, we recommend the authors to perform a survival study in G93A mice dosed with ApoA1 in both pre and post-symptomatic mice. Here, APOA1 is linked to amyotrophic lateral sclerosis.